Designing High-Quality Prospective Studies
Introduction to Prospective Study Design
- A prospective inception cohort study is the most favorable design for clinical research, providing the strongest evidence for evaluating outcomes over time, according to the American Gastroenterological Association 1
Research Question and Objectives
- The research objective(s) should be specified and classified as descriptive and/or analytical, as recommended by the European Society for Medical Oncology 2, 3
- Gaps in current evidence should be identified and explained, and a prospective study should be justified as the appropriate approach to address these gaps, as suggested by the European Society for Medical Oncology 2, 3
Study Design Elements
- The study design should be clearly identified and described to address the research question, as recommended by the European Society for Medical Oncology 2, 3
- The pre-planned sample size requirements and power calculations for the study should be specified, as suggested by the European Society for Medical Oncology 2, 3
- Eligibility criteria for participant selection should be detailed, including inclusion and exclusion criteria, as recommended by the International Society for Neuroropsychopharmacology 4 and the European Society for Medical Oncology 2
Participant Recruitment and Data Collection
- Recruitment strategies should be documented to understand potential biases in the target sample, as suggested by the International Society for Neuroropsychopharmacology 4
- Consecutive patients should be enrolled beginning at study onset to avoid selection bias, as recommended by the American Gastroenterological Association 1
Variables and Measurements
- A complete list of core variables included in the study should be provided, grouped as baseline characteristics, exposures, and outcomes, as recommended by the European Society for Medical Oncology 2, 3
- Variables should be described in detail, including timing of collection and methods of assessment, as suggested by the American Gastroenterological Association 1 and the European Society for Medical Oncology 2
Statistical Analysis Plan
- The main aspects of the statistical analysis plan should be summarized, including pre-planned strategies to identify and mitigate the main sources of bias, as recommended by the European Society for Medical Oncology 2, 3
Ethical Considerations and Reporting
- The study protocol should address ethical considerations and have appropriate approval, as recommended by the Nature Medicine editorial board 5
- The study protocol should be registered in an appropriate registry before beginning data collection, as suggested by the European Society for Medical Oncology 2, 3
- Reporting guidelines such as ARRIVE Essential 10 for animal research or BePRECISE for precision medicine research should be adhered to, as recommended by the Arteriosclerosis, Thrombosis, and Vascular Biology editorial board 6 and the Nature Medicine editorial board 5
Protocol Development for Prospective Studies
Essential Components
- The American Diabetes Association recommends using the PICO framework to structure the hypothesis, specifying the target patient population, intervention, comparator, outcome definition, and relevant time frame for outcome development 7, 8, 9
- The Annals of Internal Medicine suggests providing justification for undertaking the study, including a summary of relevant published and unpublished studies examining benefits and harms 10
- The Annals of Internal Medicine recommends clearly identifying and describing the study design, including the framework, and specifying the allocation ratio for controlled trials 10
- The BMJ advises prospectively registering the protocol in an appropriate clinical trial registry before study initiation 11
Study Design and Conduct
- The Annals of Internal Medicine suggests specifying the study setting, including geographic locations, types of facilities, and list of study sites 10
- The Annals of Internal Medicine recommends detailing eligibility criteria with specific inclusion and exclusion criteria for participants 10
- The Neuropsychopharmacology journal advises pre-specifying primary and secondary endpoints before analysis is conducted to avoid exploitation of type I error through selective reporting 12
Quality and Registration
- The BMJ recommends obtaining ethical approval from appropriate institutional review boards or ethics committees and including the trial registration number to facilitate identification in the registry 11
- The Diabetes Care journal suggests adhering to reporting guidelines such as PRISMA-P for systematic reviews, SPIRIT for clinical trials, or ARRIVE for animal research 7, 8
- The Annals of Internal Medicine advises recognizing that protocol quality is arguably one of the major determinants of overall study quality and bias 10